Skip to content
← Full study record

NCT01054196 · MORE INFO

Limitations, agreements, and source contact

Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study · Source last updated 2026-04-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
rnp2001@med.cornell.edu
organization
Weill Cornell Medicine
phone
646-962-6500
title
Roger Pearse, M.D. PhD
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
rnp2001@med.cornell.edu
organization
Weill Cornell Medicine
phone
646-962-6500
title
Roger Pearse, M.D. PhD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice